Reflections on Residency & Learning

Oncology Reflection

This month has been an interesting one. I was relieved that I was paired with my co-resident as we engaged in a lot of self-directed learning and co-teaching! We did not have many formal topic discussions so Shelby and I conducted our own with one another. We taught each other about ALL, AML, the use… Continue reading Oncology Reflection

Procedure Logs

C3.5 R2: Prepare and deliver educational seminar to pharmacists

Today I presented an interesting case about caffeine for post-dural headaches for an oncology patient. In terms of the presentation itself I thought it went fairly well. One thing I have been working on is to slow down my pace and I felt that for this presentation I was successful at speaking at a slower… Continue reading C3.5 R2: Prepare and deliver educational seminar to pharmacists

Procedure Logs

C3.2 R5: Perform and document a Best Possible Medication History (BPMH)

In our oncology patients it is very important to have a best possible medication history as their medications are constantly changing as their chemotherapy progresses. EH is a new diagnosis acute lymphoblastic leukemia who was being discharged after her first cycle of induction. I conducted a BPMH, provided a medication calendar and discharge counselling for EH’s… Continue reading C3.2 R5: Perform and document a Best Possible Medication History (BPMH)

Academic Day Seminars

ADS – Supportive Measures in Oncology

At BCCH we are fortunate to have a team of oncology pharmacists who presented an intro to peds oncology ADS, with a focus on childhood leukemias and tumour lysis syndrome. Please see below for my notes from this ADS as well as the pre-readings: Childhood leukemias: Leukemia is the most frequent malignancy that occurs during… Continue reading ADS – Supportive Measures in Oncology

Academic Day Seminars

ADS – Supportive Measures in Oncology pt. 2

Today we continued to learn about the importance of supportive care in onc patients. Specifically we spoke about Chemotherapy-induced nausea & vomiting (CINV).  Types: acute – within 24 hours of chemo delayed – 2-5 days after chemo anticipatory – prior to chemo They haven’t received the chemo, but because they have had N/V to it in… Continue reading ADS – Supportive Measures in Oncology pt. 2